Global aseptic pharma processing market is projected to register CAGR growth in the forecast years, 2023-2027 on the account of growth factors like surging demands for the hygienic packaging and increasing the shelf life of the products. Increasing demand for the eco-friendly, safe for consumption, & maintaining the quality of the consumable product is further diving the growth of the global aseptic pharma processing market in the upcoming five years. Higher demands to prolong the shelf life of medicines, drugs, therapeutic creams, etc. also influences the market growth.
Aseptic pharma processing is the pharmaceutical packaging process technique that allows commercial packaging of thermally sterilized products preferably pharmaceutical. Aseptic processing is highly preferential over terminal sterilizing for its advantage of avoiding degradation and ineffectiveness that is usually a situation during terminal sterilizing. The process guarantees removal of bacteria and other microbial interjection of the product. Terminal sterilizing is also used for the similar purpose, but the process is performed after the API, excipients, containers, and stoppers have been assembled. In certain cases, the final product loses its potency, or degrades due to extreme heat or radio-waves and in aseptic pharma processing avoids such side-effects.
Higher Investment In Pharmaceutical Industry Drives Market Growth
Consistent investments and increasing research and product development for the advanced pharmaceuticals are driving the growth of the global aseptic pharma processing market in the next five years. With increasing instances of various chronic diseases, infectious diseases, and other illnesses demand for the consistent advancement in the pharmaceutical and therapeutic products & services. Along with the governments multiple market players and private investors support the industry with higher financial investment and other resources.
In the year 2020, total nominal expenses on medicines & drugs were USD539 billion in the United States. The pandemic caused due to COVID-19 further substantiated the higher investment demands. Increased research and the demand for earliest vaccines, treatment drugs, and other therapeutics products surged the financial aids and research. Further demands for potent, safe, and no side-effect from the medicines further aid the growth of the global aseptic pharma processing market in the future five years.
Demands of Growing Pharmaceutical Industry Support Market Growth
Pharmaceutical is the most rapidly growing segment of the healthcare industry. Demands for enhancement of drugs, pharmaceutical products and therapeutic products like higher potency of the drugs, longer shelf life of the medicines, better quality, and maintenance of the standards of the drugs, drive the growth of the global aseptic pharma processing market in the forecast years. Each drug or medicine must undergo clinical trials and be approved from the food and drug administration (FDA) department to be commercialized. The manufacturing, processing, and clinical trials demands high investment and a high level of safety and potency of the product to be approved.
In United States, pharmaceutical preparation manufacturing gross output was USD217.5 billion in the year 2020. The market players are highly focused to prepare pharmaceutical products with properties that can help them to reduce the risks of high-cost product losses. Higher shelf life, potent drugs, and sterile products would guarantee reduction of risks related to high-cost product losses, and thus higher manufacturing of such product would aid the growth of the global aseptic pharma processing market in the future five years.
Click here to download the sample
Market Segmentation
The global aseptic pharma processing market segmentation is based on component, technology, product, application, regional distribution, and competitive landscape. Based on component, the market is differentiated between processing equipment and packaging equipment. Processing equipment include drying equipment, extruders, granulation equipment, tablet compression, fill/finish equipment, mixing equipment, and others. Packaging equipment include inspection machines, labelling machines, and aseptic packaging machines. Market segment by technology, is further bifurcated into drying, lyophilization, closed vial technology, blow fill seal technology, and others. Also, by product segmentation includes corticosteroids, antibiotics, antagonists, biologics, and others. Based on application, the market is further fragmented into ophthalmic suspensions, reconstituted lyophilized powders for injection, sterile injectables, aqueous-based aerosols for inhalation, and others.
Company Profile
Abbvie Inc., Lonza Group, Baxter International Inc., Recipharm AB, August Bioservices, LLC, Vetter Pharma-Fertigung GmbH & Co. KG, Berkshire Sterile Manufacturing, Recro Pharma Inc., Samsung Biologics, Symbiosis Pharmaceutical Services Ltd., Catalent Pharma Solutions Inc., Alcami Corporation, LSNE Contract Manufacturing, IRISYS, Robert Bosch GmbH, are enlisted in a partial list of major market players of the global aseptic pharma processing market.
Attribute | Details |
Base Year | 2021 |
Historical Data | 2017 – 2020 |
Estimated Year | 2022 |
Forecast Period | 2023 – 2027 |
Quantitative Units | Revenue in USD Million, and CAGR for 2017-2021 and 2022-2027 |
Report coverage | Revenue forecast, company share, competitive landscape, growth factors, and trends |
Segments covered | · Component · Technology · Product · Application |
Regional scope | North America; Europe; Asia Pacific; South America; Middle East & Africa |
Country scope | United States, Mexico, Canada, China, India, Japan, South Korea, Australia, Germany, France, United Kingdom, Spain, Italy, South Africa, UAE, Saudi Arabia, Brazil, Argentina, Colombia. |
Key companies profiled | Abbvie Inc., Lonza Group, Baxter International Inc., Recipharm AB, August Bioservices, LLC, Vetter Pharma-Fertigung GmbH & Co. KG, Berkshire Sterile Manufacturing, Recro Pharma Inc., Samsung Biologics, Symbiosis Pharmaceutical Services Ltd., Catalent Pharma Solutions Inc., Alcami Corporation, LSNE Contract Manufacturing, IRISYS, Robert Bosch GmbH |
Customization scope | 10% free report customization with purchase. Addition or alteration to country, regional & segment scope. |
Pricing and purchase options | Avail customized purchase options to meet your exact research needs. Explore purchase options |
Delivery Format | PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request) |
